You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KZIA Award Disclosure
Levine James E. · SEC Form 4 · Filed Jun 23, 2026
Award
Calculated transaction value
$0
Levine James E. Chief Financial Officer
Transaction date
Jun 19, 2026
Public filing date
Jun 23, 2026
Filing lag
Filed 4 days later
KZIA daily price context
Close on/before transaction
$13.86
Jun 18, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on ADSs
- Quantity / price
- 200,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-071231
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kazia Therapeutics Ltd KZIA Current | Award | Jun 19, 2026 | $0 |